Sulphur Burps & Diarrhoea: Retatrutide | Cured Pharmacy
Sulphur Burps and Diarrhoea from Retatrutide: Causes and Management
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER
Understanding Sulphur Burps and Diarrhoea from Retatrutide
Sulphur burps are a common digestive side effect reported by patients using retatrutide and similar GLP-1 receptor agonist medications for weight management. These distinctive burps, characterised by a rotten egg odour, occur alongside diarrhoea in many cases and typically result from delayed gastric emptying—a therapeutic mechanism of these medications [1]. Understanding why these symptoms occur and how to manage them effectively can help you continue your weight loss journey with greater comfort.
Why Retatrutide Causes Sulphur Burps and Digestive Changes
Retatrutide is a triple agonist medication that activates GLP-1, GIP, and glucagon receptors simultaneously, producing profound effects on gastric motility [1]. The GLP-1 component specifically slows how quickly food moves through your digestive system, which is precisely how these medications help control appetite and blood sugar levels.
When food remains in your stomach longer than usual, bacterial fermentation increases, producing hydrogen sulphide gas—the compound responsible for the characteristic rotten egg smell of sulphur burps [2]. This same delayed emptying can also trigger loose stools or diarrhoea as your intestines adjust to altered transit times.
Clinical trials of similar GLP-1 medications like tirzepatide (Mounjaro) reported gastrointestinal side effects in approximately 30-40% of participants during dose escalation phases, with most symptoms improving after 4-8 weeks of continued use [3]. Sulphur burps specifically tend to occur when dietary fat intake remains high whilst gastric emptying is significantly slowed.
Dietary Modifications to Reduce Sulphur Burps
The most effective strategy for managing sulphur burps involves adjusting your macronutrient intake, particularly reducing dietary fat and sulphur-rich foods during the initial treatment period. High-fat meals take considerably longer to digest and are more likely to trigger symptoms when combined with medication-induced gastric delay [2].
Sulphur-containing foods such as eggs, red meat, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions, and dairy products can exacerbate symptoms. Temporarily reducing these whilst your body adjusts to retatrutide often provides significant relief within 48-72 hours.
Smaller, more frequent meals—rather than three large daily meals—help prevent gastric overload and reduce fermentation time. Aim for portions roughly the size of your fist, eaten every 3-4 hours, focusing on lean proteins, easily digestible carbohydrates, and cooked rather than raw vegetables during the adaptation phase.
Foods to Prioritise During Treatment
Well-tolerated options include plain chicken or turkey, white fish, rice, oats, bananas, cooked carrots, and clear broths. These low-residue, low-fat choices move through your digestive system more efficiently and produce less gas during breakdown. Staying well-hydrated with at least 2 litres of water daily also supports digestive function and helps prevent constipation, which can worsen sulphur burps.
Managing Diarrhoea Alongside Sulphur Burps from GLP-1 Medications
Diarrhoea commonly accompanies sulphur burps during the initial weeks of GLP-1 treatment, affecting roughly 20-30% of patients starting medications like Mounjaro or Wegovy [3]. This occurs because altered gastric emptying affects your entire gastrointestinal tract, not just your stomach.
The key distinction to make is between temporary adjustment diarrhoea—which typically resolves within 2-4 weeks—and persistent symptoms that may indicate intolerance or require dose adjustment. If you're experiencing more than 4-5 loose stools daily, or if symptoms persist beyond one month, contact your prescriber for review.
Practical management includes avoiding caffeine and artificial sweeteners (particularly sorbitol and mannitol), which can worsen loose stools. Probiotic supplementation may help restore gut flora balance, though evidence remains mixed in GLP-1 users [4]. Over-the-counter loperamide can provide short-term relief for occasional severe episodes, but shouldn't be used routinely without medical guidance.
When Diarrhoea Requires Medical Attention
Seek immediate medical advice if you develop signs of dehydration (dark urine, dizziness, reduced urination), blood in stools, severe abdominal pain, or fever alongside diarrhoea. These symptoms may indicate complications requiring urgent assessment rather than simple medication adjustment. Your UK prescriber can evaluate whether dose reduction, temporary treatment pause, or alternative weight management options would be more appropriate.
| Medication | Mechanism | Sulphur Burps Risk | Starting Price |
|---|---|---|---|
| Mounjaro (tirzepatide) | Dual GIP/GLP-1 agonist | Moderate (20-35%) | From £145.00 |
| Wegovy (semaglutide) | GLP-1 agonist | Moderate (18-30%) | From £89.00 |
| Saxenda (liraglutide) | GLP-1 agonist (daily) | Moderate-Low (15-25%) | From £68.00 |
| Orlistat | Fat absorption blocker | Rare (<5%) | From £32.00 |
Comparing Sulphur Burps Across Different Weight Loss Medications
Whilst retatrutide is still undergoing clinical trials in the UK, similar digestive side effects occur with currently licensed GLP-1 medications including Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide). The frequency and severity of sulphur burps varies based on each medication's receptor activity profile and dosing schedule [1][3].
Mounjaro, as a dual GIP/GLP-1 agonist, produces comparable gastric emptying effects to retatrutide, with approximately 35% of users reporting nausea and 20% experiencing diarrhoea during dose escalation [3]. Wegovy users report similar rates, whilst Saxenda—requiring daily rather than weekly injections—may cause more consistent but potentially milder day-to-day symptoms.
Importantly, medications like Orlistat work through an entirely different mechanism (blocking fat absorption rather than affecting gastric emptying) and do not typically cause sulphur burps. However, Orlistat produces its own distinct digestive effects, including oily stools and increased bowel urgency when dietary fat intake is high.
Practical Tips to Stop Sulphur Burps Quickly
When sulphur burps occur, several immediate interventions can provide relief within hours. Peppermint tea or diluted apple cider vinegar (one tablespoon in warm water) may help neutralise stomach acid and reduce gas production, though clinical evidence for these traditional remedies remains limited [2].
Over-the-counter antacids containing simethicone can break down gas bubbles in your digestive tract, making them easier to expel without the sulphurous odour. Taking these 30 minutes after meals during symptomatic periods often provides noticeable improvement.
Gentle physical activity—such as a 10-15 minute walk after eating—encourages gastric emptying and reduces the stagnation that promotes bacterial fermentation. Avoid lying down for at least 2-3 hours after meals, as this can worsen reflux and prolong stomach emptying time, exacerbating sulphur burps.
Long-Term Prevention Strategies
As your body adapts to retatrutide over 8-12 weeks, most patients find sulphur burps decrease significantly even without ongoing dietary restrictions. Gradually reintroducing previously problematic foods—one at a time—helps identify your personal triggers. Maintaining a food and symptom diary during the first three months of treatment provides valuable insights for both you and your prescriber when optimising your regimen.
Alternative Weight Loss Treatments at Cured Pharmacy
If persistent sulphur burps and digestive symptoms significantly affect your quality of life despite management strategies, discussing alternative weight loss medications with your UK prescriber may be appropriate. At Cured Pharmacy, our clinical team can assess whether switching to a different GLP-1 medication, adjusting your dose, or considering non-GLP-1 options would better suit your needs.
Mounjaro (tirzepatide) is available with transparent upfront pricing and has demonstrated average weight loss of 22.5% in clinical trials [3]. For patients who find injectable GLP-1 medications difficult to tolerate, Orlistat-based treatments work through fat malabsorption rather than affecting gastric emptying, eliminating sulphur burps entirely—though they carry their own distinct digestive considerations.
All prescription weight loss medications available through Cured Pharmacy require a free online consultation with a UK-registered prescriber, typically completed in under 3 minutes. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all dispensing to ensure you receive genuine UK-licensed medications with comprehensive patient information and ongoing support throughout your treatment journey.
Starting Your Weight Loss Journey Safely
Whether you're considering Mounjaro, Wegovy, Saxenda, or alternative treatments, understanding potential side effects like sulphur burps before starting therapy helps set realistic expectations. Our clinical team provides detailed pre-treatment counselling on managing common side effects, optimising your diet during the adjustment period, and recognising symptoms that require medical review. With proper preparation and support, most patients successfully navigate initial digestive changes and achieve meaningful, sustained weight loss.
Scientific References
- Jastreboff, A. M., et al. (2023). Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine, 389(6), 514–526. https://doi.org/10.1056/NEJMoa2301972
- Marathe, C. S., et al. (2013). Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function. Experimental Diabetes Research, 2013, 1-13. https://doi.org/10.1155/2013/279530
- Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6
- Nauck, M. A., et al. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience severe or persistent side effects, contact your prescriber or seek urgent medical attention.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your Account